These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
162 related items for PubMed ID: 29804819
1. Circulating microRNA miR-21-5p, miR-150-5p and miR-30e-5p correlate with clinical status in late onset myasthenia gravis. Sabre L, Maddison P, Sadalage G, Ambrose PA, Punga AR. J Neuroimmunol; 2018 Aug 15; 321():164-170. PubMed ID: 29804819 [Abstract] [Full Text] [Related]
4. Short-term changes in serum miRNA levels and patient-reported clinical outcomes in myasthenia gravis. Huang YF, Bhandage AK, Adeström LD, Punga AR. Muscle Nerve; 2024 Aug 15; 70(2):284-289. PubMed ID: 38855861 [Abstract] [Full Text] [Related]
5. Towards Personalized Medicine in Myasthenia Gravis: Role of Circulating microRNAs miR-30e-5p, miR-150-5p and miR-21-5p. Beretta F, Huang YF, Punga AR. Cells; 2022 Feb 20; 11(4):. PubMed ID: 35203389 [Abstract] [Full Text] [Related]
6. Circulating microRNAs as potential biomarkers in myasthenia gravis patients. Punga AR, Punga T. Ann N Y Acad Sci; 2018 Jan 20; 1412(1):33-40. PubMed ID: 29125182 [Abstract] [Full Text] [Related]
12. Circulating miRNAs as diagnostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance. Li J, Zhang M, Wang C. J Clin Lab Anal; 2020 Jun 20; 34(6):e23233. PubMed ID: 32039495 [Abstract] [Full Text] [Related]
13. Disease specific enrichment of circulating let-7 family microRNA in MuSK+ myasthenia gravis. Punga T, Bartoccioni E, Lewandowska M, Damato V, Evoli A, Punga AR. J Neuroimmunol; 2016 Mar 15; 292():21-6. PubMed ID: 26943954 [Abstract] [Full Text] [Related]